Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.
about
Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccineComplex adaptive immunity to enteric fevers in humans: lessons learned and the path forwardLive-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent DeliveryOverview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®)Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trialThe vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteersAssessment of the duration of protection in Campylobacter jejuni experimental infection in humansSalmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid.Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technologyOral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosisOral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans.Flagella overexpression attenuates Salmonella pathogenesisOral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humansHead-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trialDetection of antibodies to the biofilm exopolysaccharide of Histophilus somni following infection in cattle by enzyme-linked immunosorbent assayEvaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cellsT- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccineDirect visualization of endogenous Salmonella-specific B cells reveals a marked delay in clonal expansion and germinal center development.A Cronobacter turicensis O1 antigen-specific monoclonal antibody inhibits bacterial motility and entry into epithelial cells.Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study.Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.Enteric pathogens as vaccine vectors for foreign antigen deliveryAntibody responses to Escherichia coli O157 and other lipopolysaccharides in healthy children and adults.Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humansHomologous prime-boost immunization with live attenuated Salmonella enterica serovar Senftenberg and its preventive efficacy against experimental challenge with various strains of S. Senftenberg.Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag.Live oral Salmonella enterica serovar Typhi vaccines Ty21a and CVD 909 induce opsonophagocytic functional antibodies in humans that cross-react with S. Paratyphi A and S. Paratyphi BGeneration of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans.Design of a protein-targeting system for lactic acid bacteria.Lipopolysaccharide-specific but not anti-flagellar immunoglobulin A monoclonal antibodies prevent Salmonella enterica serotype enteritidis invasion and replication within HEp-2 cell monolayers.Use of a novel antigen expressing system to study the Salmonella enterica serovar Typhi protein recognition by T cells.Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine.Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.
P2860
Q21245322-14657C9E-E327-478E-AC1E-3EBB70527AD5Q27694492-C57379F1-A19A-4C39-9B7F-4914F4663868Q28084076-4D0157EC-6A5C-49FB-8060-78E70061343BQ33690625-5F0F3DA2-CE90-41CD-B664-AC459DC67D17Q33751908-1B3ABB27-86C4-4033-887C-E48E8E64E225Q33768926-AF2A67FC-6C6D-4572-9FDA-8D813705082FQ33769012-0651AD54-3B6A-4351-8A16-40F0AA298EB9Q33828828-E71E78B3-8C8A-448C-81B3-35C42A7DF130Q34044935-2A4F3B49-1163-4D6A-8B66-41208611EC85Q34122078-A338FE35-5328-46DC-A4CC-F4DE8605371BQ34131647-FCCB6F7C-562C-4A7C-BD1E-F1798DB5EA03Q34442222-394E7E2A-9103-4019-B3C9-322B4206087BQ34562262-628B645C-0375-48DF-AB14-3C121BE2D36EQ34673466-95E45A93-E123-4EA7-80BE-E20475870207Q34701396-5DF3E8B0-E924-4E05-A18A-35FEA205EFC3Q34717658-37848C91-F349-4EC9-9251-6E37BC7B99AFQ34995847-4F4BBDF0-EBEE-4C2A-BB95-BF3C639324CAQ35071000-FBD17BC8-7350-498B-986C-62CECBA4C19DQ35098202-17A2DA16-EE6E-4D13-BE54-F6117A421671Q35185518-1F7AAA2C-9301-477A-A0E4-3F9F93D65D62Q35729793-B9639D70-78B7-4027-ACD0-EF35148D6BF7Q35896020-B26D95A1-EEE4-4F58-9D80-2904733582B6Q35923378-6CE30BC0-780F-496E-A2FC-670ACA2FAF79Q36017715-3558B265-E0D1-4E39-930C-FE8D0B3D7162Q36265689-D2F8A3D5-C6BF-409A-8849-877C5B5205E1Q36517179-6FC40794-2065-41E2-A2CD-E62866399DE3Q37235277-0D192257-6D8A-4E65-97E7-B27ED4E97058Q37643333-454DDCC9-F9D8-4DB5-A953-88E81E8C097FQ39081934-18746CF4-EA9E-4250-8D12-8EBB7589C057Q39504123-E856043F-416F-4DD0-AC4B-8BB0596C7EB6Q39654238-36B3292F-75F4-40AD-8F63-0C044B9ED03FQ40040654-A127F7D3-E8DB-42CB-9AB9-05ECE2491688Q47629539-8C7471F1-549D-4137-90DD-296266845922Q52725104-BDB436A3-E7D0-44C6-A2A7-A966538B1D3A
P2860
Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Mucosal and systemic immune re ...... sive live attenuated bacteria.
@ast
Mucosal and systemic immune re ...... sive live attenuated bacteria.
@en
type
label
Mucosal and systemic immune re ...... sive live attenuated bacteria.
@ast
Mucosal and systemic immune re ...... sive live attenuated bacteria.
@en
prefLabel
Mucosal and systemic immune re ...... sive live attenuated bacteria.
@ast
Mucosal and systemic immune re ...... sive live attenuated bacteria.
@en
P2093
P2860
P1476
Mucosal and systemic immune re ...... sive live attenuated bacteria.
@en
P2093
B Wegmüller
P2860
P304
P407
P577
1999-07-01T00:00:00Z